Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.
2 reports, 2 independent
Updated Jun 17
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Geode Capital Management increased its stake in Amgen.1 source
Geode Capital Management bought a new stake in Amgen stock.1 source
Keep exploring
The entities involved
-
Geode Capital Management
American Investment Management firm based in Boston, Massachusetts
- Geode Capital Management, Mizuho Securities, and Manufacturers Life Insurance Company increased their holdings and raised their target price/rating on MBX Biosciences stock.
- Geode Capital Management, Royal Bank of Canada, and Canadian Imperial Bank of Commerce have taken actions regarding Equinox Gold Corp., including lifting positions and restating ratings.
-
Amgen
American multinational biopharmaceutical company